Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss ...

CERA Deputy Director and Head of Macular Research Professor Robyn Guymer AM and CERA Head of Ophthalmic Epidemiology Research ...

Blagosklonny goes on to write that even though rapamycin may reverse some manifestations of aging, it is more effective at ...

Ireland has become the first country to recruit patients onto a new global clinical trial into a potential treatment for a ...

Raw papaya is a superfood, which is packed with essential vitamins, minerals, and powerful enzymes. It is rich in papain, a ...

Dr. Yifan Jian explores the evolution of OCT, challenges in retinal imaging, and AI's potential in biophotonics, shaping the ...

Spring is a time of renewal and vibrancy, but it also brings unique challenges for our eyes. As we shed the winter layers and ...

Do you know the "three C's of measles"? As measles outbreaks emerge in the U.S., it is important to know the symptoms and ...

Aviceda Therapeutics ("Aviceda"), a private, clinical-stage biotech company focused on developing next-generation immunomodulators incorporating its proprietary High Affinity Ligands of Siglecs ...

The Health Action Wānaka-led report found some people were prepared to lose their eyesight because it was too difficult to ...

Bill Felker reflects on 40-years of sharing ideas and observations through "Poor Will's Almanack on WYSO. The last day for ...

A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. An archive of the webcast will be available for three months.